Skip to main content
. 2011 Feb 18;12(3):355–360. doi: 10.1007/s10194-011-0306-8

Table 1.

The clinical and laboratory characteristics of all participants

Migraine subjects (n = 50) Control subjects (n = 25) p
Age (years) 38.0 ± 8.6 34.4 ± 7.8 Ns
Hypertension (%) 9.3 9.0 Ns
Diabetes mellitus (%) 4.4 0 Ns
Smoking (%) 42.4 50 Ns
BMI (kg/m2) 26.54 ± 5.52 23.98 ± 3.18 <0.05
Systolic BP (mmHg) 118.09 ± 17.4 123.63 ± 23.77 Ns
Diastolic BP (mmHg) 77.44 ± 16.34 77.27 ± 11.03 Ns
Glucose (mg/dl) 91.76 ± 10.76 93.85 ± 22.8 Ns
Cholesterol (mg/dl) 189.88 ± 38.04 183.42 ± 40.28 Ns
Triglyceride (mg/dl) 106.21 ± 44.54 102.85 ± 53.97 Ns
LDL (mg/dl) 119.92 ± 32.38 111.68 ± 32.90 Ns
HDL (mg/dl) 50.03 ± 12.52 49.29 ± 15.88 Ns
Platelet (/mm3) 274361 ± 59207 263062 ± 60698 Ns
MPV (fL) 9.53 ± 1.4 8.7 ± 0.92 <0.05
Prolactin (ng/mL) 11.34 ± 8.63 10.89 ± 5.0 Ns
hs-CRP (mg/L) 4.28 ± 4.01 3.91 ± 3.89 Ns
sCD40L (ng/mL) 11.92 ± 5.26 7.72 ± 3.6 <0.001

Ns non-significant, BP blood pressure, MPV mean platelet volume, hsCRP high-sensitivity C-reactive protein, sCD40L soluble CD40 ligand